HealthEquity Sees FY24 Adj. EPS $1.97-$2.06 vs $1.92 Est., Revenue $980M-$990M vs $981.07M Est.
Portfolio Pulse from Benzinga Newsdesk
HealthEquity has projected its FY24 adjusted EPS to be between $1.97 and $2.06, which is higher than the estimated $1.92. The company also expects its revenue to be between $980M and $990M, slightly below the estimated $981.07M.
September 05, 2023 | 8:01 pm
News sentiment analysis
Sort by:
Descending
NEUTRAL IMPACT
HealthEquity's higher than expected EPS forecast for FY24 could positively impact its stock. However, the slightly lower revenue forecast could offset this positive impact.
The higher EPS forecast indicates that HealthEquity is expected to have higher profitability, which is a positive signal for investors. However, the slightly lower revenue forecast could indicate potential challenges in sales or market growth, which could negatively impact investor sentiment.
CONFIDENCE 85
IMPORTANCE 80
RELEVANCE 100